Seven years of qualification
Audited Supplier
In This Store
Category:Natural Extracts > Food & Beverage Raw Materials
Product Name:L-Glutamine
Standard:ChP
Price(USD):50
Company:Xi'an DN Biology Co., Ltd
Grade: Pharmaceutical Grade
Factory Location: Xianyang, Shaanxi Province, China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 1000KG/MONTH
Contract Manufacturing: CRO
Packaging Information: Double plastic bag inside, aluminum foil bag or fiber drum outside
Delivery Lead Time: in 7 days
Sample Provided: yes
Payment Terms: T/T, Paypal, L/C
L-Glutamine 99%
|
Type |
L-Glutamine Powder |
|
Form |
Powder |
|
Extraction Type |
Solvent Extraction |
|
Packaging |
Drum, Plastic Container |
|
Place of Origin |
China |
|
Shaanxi |
|
|
Grade |
Food Grade |
|
Brand Name |
QYHerb |
|
Model Number |
L-Glutamine |
|
Application |
Health Food |
|
Origine |
100% Raw Material |
|
Product Name |
L-Glutamine Powder |
|
Appearance |
White Powder |
|
Specification |
99% Purity |
|
Certificate |
ISO9001/Halal/Kosher/GMP |
|
Shelf Life |
24 Months |
|
MOQ |
1kg |
|
Storage |
Cool Dried Storage |
|
Sample |
Free Sample 5-20g |
|
Package |
1kg/ Bag 25kg/drum |
|
OEM/ODM |
Accepatable |
Applications：
1. Used for biochemical research, medical for peptic ulcer, mental disorders, alcoholism, epilepsy brain dysfunction and other diseases, used to improve intellectual dysplasia children.
2. Nutrition supplement, seasoning and fragrance enhancer. It is used in medicine to treat ulcer of digestive organs, alcohol poisoning and improve brain function.
3. The product is converted into glycoamine in the body, as the precursor of mucin synthesis, can promote ulcer healing, mainly used as digestive tract ulcer medicine. In addition, it can also be used as a brain function enhancer and in the treatment of alcoholism.
4. Biochemical research, bacterial medium.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094
Follow Us：
Pharma Sources Insight January 2025
